Search by Drug Name or NDC

    NDC 51672-4044-03 Clorazepate Dipotassium 15 mg/1 Details

    Clorazepate Dipotassium 15 mg/1

    Clorazepate Dipotassium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is CLORAZEPATE DIPOTASSIUM.

    Product Information

    NDC 51672-4044
    Product ID 51672-4044_a22613cd-20d8-4b29-8520-d66368b47ea0
    Associated GPIs 57100030100320
    GCN Sequence Number 003744
    GCN Sequence Number Description clorazepate dipotassium TABLET 15 MG ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 14090
    HICL Sequence Number 001612
    HICL Sequence Number Description CLORAZEPATE DIPOTASSIUM
    Brand/Generic Generic
    Proprietary Name Clorazepate Dipotassium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clorazepate Dipotassium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name CLORAZEPATE DIPOTASSIUM
    Labeler Name Taro Pharmaceuticals U.S.A., Inc.
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA075731
    Listing Certified Through 2024-12-31

    Package

    NDC 51672-4044-03 (51672404403)

    NDC Package Code 51672-4044-3
    Billing NDC 51672404403
    Package 1000 TABLET in 1 BOTTLE (51672-4044-3)
    Marketing Start Date 2000-04-27
    NDC Exclude Flag N
    Pricing Information N/A